You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABO incompatibility

Showing 1 - 25 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Transplant, ABO Incompatibility Trial in Toronto (Blood group A2 donor to blood group O recipient lung transplant surgery)

Recruiting
  • Lung Transplant
  • ABO Incompatibility
  • Blood group A2 donor to blood group O recipient lung transplant surgery
  • Toronto, Ontario, Canada
    Toronto General Hospital, University Health Network
Dec 8, 2022

ETCOc in the Diagnosis and Treatment of ABO-HDN

Not yet recruiting
  • ABO Hemolytic Disease of Newborn
    • (no location specified)
    May 2, 2023

    Donor-recipient ABO Matching on Haploidentical Stem Cell

    Completed
    • Hematological Malignancies
    • Haploidentical Stem Cell Transplantation
    • no intervention
    • Hangzhou, Zhejiang, China
    • +1 more
    Oct 22, 2021

    Neonatal Cord Blood Screening for HDN

    Not yet recruiting
    • HDN - Hemolytic Disease of the Newborn
      • (no location specified)
      Nov 8, 2022

      ABO Blood Type Incompatible Kidney Transplantation, Antibody-mediated Rejection Trial in Seoul (5-gene classification model)

      Active, not recruiting
      • ABO Blood Type Incompatible Kidney Transplantation
      • Antibody-mediated Rejection
      • 5-gene classification model
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Oct 24, 2022

      Myelodysplastic Syndrome Trial (RBC transfusion)

      Not yet recruiting
      • Myelodysplastic Syndrome
      • RBC transfusion
      • (no location specified)
      Aug 24, 2022

      Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body

      Recruiting
      • Sickle Cell Disease
      • +3 more
      • Calgary, Alberta, Canada
        Alberta Children's Hospital
      May 25, 2021

      Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

      Recruiting
      • Sickle Cell Disease
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Analyse the Correlation Between CAI and Bilirubin

      Not yet recruiting
      • Hemolysis Neonatal
      • Urine sample for carbonic anydrase (I) levels
      • (no location specified)
      Mar 17, 2022

      GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating

      Active, not recruiting
      • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
        • Durham, North Carolina
          RTI Health Solutions
        Jun 14, 2022

        Blood Transfusion Complication Trial in Brussels (ABODpoct device)

        Recruiting
        • Blood Transfusion Complication
        • ABODpoct device
        • Brussels, Belgium
          CHU Brugmann
        Sep 28, 2021

        Its Resistance Pattern Among Patient With Neonatal Sepsis

        Not yet recruiting
        • Neonatal Sepsis
        • (no location specified)
        Feb 14, 2023

        Gastric/Colorectal Cancers

        Not yet recruiting
        • Gastric Cancer
        • Colo-rectal Cancer
        • quantitative Real-time PCR
        • (no location specified)
        Nov 27, 2023

        Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,

        Completed
        Has Results
        • Disorder Related to Bone Marrow Transplantation
        • +2 more
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Nov 18, 2021

        ABO Blood Group Type Association With COVID-19 Severity

        Completed
        • COVID-19
        • +4 more
        • No Intervention
        • Colton, California
          Arrowhead Regional Medical Center
        May 15, 2023

        Comparing Immune Responses to Topical Imiquimod

        Active, not recruiting
        • Actinic Keratoses
        • Sacramento, California
          University of California Davis
        Jul 8, 2022

        Study of Patients With MPS IIIA Treated With ABO-102

        Enrolling by invitation
        • Mucopolysaccharidosis III-A
        • ABO-102
        • Columbus, Ohio
        • +2 more
        Nov 8, 2022

        Acute Lymphoblastic Leukemia Trial in Petach Tikvah (Transplantation with Stem Cells from Umbilical Cord)

        Completed
        • Acute Lymphoblastic Leukemia
        • Transplantation with Stem Cells from Umbilical Cord
        • Petach Tikvah, Israel
          Schneider Children's Medical Center of Israel
        Mar 24, 2021

        Type2 Diabetes Trial in Padova (ABO-GLYC, ABO-GLYC Placebo)

        Completed
        • Type2 Diabetes
        • ABO-GLYC
        • ABO-GLYC Placebo
        • Padova, Italy
          Azienda Ospedaliera Padova
        Jun 28, 2022

        Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)

        Terminated
        • Decreased Immunologic Activity
        • Antibody-mediated Rejection
        • Combined apheresis
        • Vienna, Austria
          Division of Medicine III, Dpt. of Nephrology and Dialysis, Medic
        Aug 22, 2022

        Kinetics of Extracellular Vesicles in Hemodialysis

        Not yet recruiting
        • End-stage Kidney Disease
        • Routine hemodialysis
        • (no location specified)
        Jul 13, 2023

        Study of Patients With MPS IIIB Treated With ABO-101

        Terminated
        • Mucopolysaccharidosis III-B
        • ABO-101
        • Columbus, Ohio
        • +2 more
        May 25, 2022

        Less Than 10 g/dl Postoperatively in Scheduled Hip or Knee

        Active, not recruiting
        • Hip Prosthetic Surgery
        • Knee Prosthetic Surgery
          • Paris, France
            Groupe Hospitalier Paris Saint-Joseph
          Oct 31, 2022

          Infectious and Inflammatory Complications in Acute Bowel

          Recruiting
          • Intestinal Obstruction
          • +4 more
          • LBP
          • +2 more
          • Karaganda, Kazakhstan
            NJSC Karaganda Medical University
          Feb 3, 2022

          Liver Transplantation Trial in Seongnam, Seoul (LIV-GAMMA SN Inj., No intervention)

          Recruiting
          • Liver Transplantation
          • LIV-GAMMA SN Inj.
          • No intervention
          • Seongnam, Korea, Republic of
          • +5 more
          Dec 24, 2022